5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.25▲ | 1.25▲ | 1.26▼ | 1.30▼ | 1.06▲ |
MA10 | 1.25▲ | 1.26▼ | 1.27▼ | 1.20▲ | 0.91▲ |
MA20 | 1.25▼ | 1.28▼ | 1.28▼ | 0.99▲ | 0.85▲ |
MA50 | 1.27▼ | 1.27▼ | 1.25▲ | 0.84▲ | 0.82▲ |
MA100 | 1.30▼ | 1.23▲ | 1.12▲ | 0.80▲ | 1.59▼ |
MA200 | 1.27▼ | 1.09▲ | 0.90▲ | 0.78▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | -0.005▼ | -0.011▼ | 0.031▲ | 0.074▲ |
RSI | 45.194▼ | 44.314▼ | 47.750▼ | 62.214▲ | 59.871▲ |
STOCH | 63.889 | 16.061▼ | 14.398▼ | 74.834 | 63.004 |
WILL %R | -33.333 | -86.667▼ | -95.000▼ | -27.941 | -19.691▲ |
CCI | 107.280▲ | -60.769 | -80.912 | 71.815 | 177.897▲ |
MA | $IVVD Price Crossed Below MA(7) | Set Alert |
Wednesday, September 17, 2025 04:14 AM
Invivyd, Inc. (Nasdaq: IVVD) today announced the appointment of Kristie Kuhl as Chief Communications Officer. Ms. Kuhl will lead the Company’s communications and patient advocacy efforts as Invivyd ...
|
Thursday, September 04, 2025 04:10 AM
SPEAR proposal reflects current evidence on monoclonal antibodies in treatment for Long COVID and identifies VYD2311 as a promising next-generation candidate for the clinical study Recommendation is ...
|
Friday, August 29, 2025 07:55 AM
Invivyd's monoclonal antibody (mAb) VYD2311 is a prophylactic for COVID has greater efficacy and less side effects than COVID vaccines. The current administration's clear goal of minimizing the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 1.30 | 1.32 | 1.23 | 1.26 | 1,820,623 |
15/09/25 | 1.41 | 1.41 | 1.25 | 1.28 | 2,737,175 |
12/09/25 | 1.24 | 1.45 | 1.05 | 1.43 | 10,287,989 |
11/09/25 | 1.29 | 1.3483 | 1.215 | 1.23 | 3,216,264 |
10/09/25 | 1.21 | 1.45 | 1.2003 | 1.29 | 8,809,369 |
09/09/25 | 1.17 | 1.24 | 1.11 | 1.22 | 3,112,890 |
08/09/25 | 1.13 | 1.21 | 1.11 | 1.16 | 2,643,214 |
05/09/25 | 0.97 | 1.19 | 0.9601 | 1.14 | 7,611,303 |
04/09/25 | 1.03 | 1.04 | 0.958 | 0.9975 | 3,296,974 |
03/09/25 | 1.02 | 1.09 | 1.00 | 1.04 | 2,917,587 |
|
|
||||
|
|
||||
|
|